Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
133155-89-2O=C1N[C@@H](Cc2ccccc2)C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](CCCCCC(=O)[C@@H]2CO2)C(=O)N[C@H]1Cc1ccccc1GXVXXETYXSPSOA-UFEOFEBPSA-N133155-89-2DTXSID20927982CHEMBL274445、CHEMBL6087370CHEBI:84057Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungTrapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor. It inhibits HDAC activity in a concentration-dependent and irreversible manner. Trapoxin A inhibits proliferation of NIH3T3 cells transformed by the oncogene v-sis (sis/NIH3T3; IC50 = ~200 ng/ml) and has detransformation activity, flattening sis/NIH3T3 cells when used at a concentration of 1 ng/ml. It also halts the cell cycle at the G2 phase in 3Y1 fibroblasts when used at a concentration of 10 nM and inhibits growth of TR303 cells resistant to trichostatin A at a concentration of 50 ng/ml.
VerwendenTrapoxin A has been used:to study its effects on the inhibition of histone deacetylase 11 (HDAC11)to study its effects on the inhibition of HDAC3 in human cell linesto study its effects on the inhibition of HDAC6 in rat pyramidal neurons
DefinitionChEBI: A homodetic cyclic tetrapeptide constructed from L-phenylalanyl (x2), D-pipecolinyl and L-2-amino-8-oxo-9,10-epoxydecanoyl residues.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…